Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (2824)	11/25/1997 10:34:00 PM
From: DR. BOND	Read Replies (3) \| Respond to of 23519

BK...I absolutely agree w/98% of your posts. It is our opinion (our being a MAJOR WALL ST. Firm) that indeed Viagra will get approval and yes, Viagra will be an effective frontline ED therapy. But we also believe, that the ED market is so HUGE, that MANY PLAYERS WILL WIN ( as stated many times by yourself). So I don't know what the issue is here. Anyone with half a brain about the ED market and those companies who are PLAYERS, knows that PFE and VVUS will BOTH have their SHARE of the market. MUSE already has a strong foothold in the marketplace and with the introduction of EUROPE IMMINENT, millions (OK..maybe only 1 million <ggg>) more men will have tried MUSE before Viagra is ever prescribed. But, yes you are both accurate and fair in all your posts, which I for one enjoy reading. GO VVUS and PFE! RESPECTFULLY, Dr. Bond

To: BigKNY3 who wrote (2824)	11/25/1997 11:11:00 PM
From: MisterED	Read Replies (1) \| Respond to of 23519

BigKNY, again I am impressed by the ever present Pfizer PR-machine. Keep repeating the same old stuff and always getting their name in there.